TEAD4 and autosomal dominant polycystic kidney disease: To determine whether the SNX9-induced inhibition of ADPKD development was mediated by the Hippo pathway, the YAP/TEAD4 inhibitor verteporfin (Weiler et al., 2017) was used to treat SNX9-depleted RCTEC and MDCK cells.